CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Clinical Trials Arena
Original article

Prilenia and Ferrer begin Phase III trial of Huntington’s therapy

Phase 3pridopidinePositive
AI Analysis

Summary

Prilenia Therapeutics and Ferrer have initiated the Phase III PRECISE-HD confirmatory trial evaluating pridopidine as a treatment for Huntington's disease.

Clinical Trial Data

Phase

Phase III

Importance:6/10
Sentiment:
0.40
Huntington's diseasepridopidinePhase IIIPRECISE-HD trialconfirmatory trial
Related Companies

Read the original article

Published by Clinical Trials Arena on July 8, 2026 8:03 AM

Read Original